Navigation Links
Okyanos Heart Institute Inks Deal With International Med-X and Philips Healthcare For Cardiac Cath Lab Equipment To Treat Heart Disease Patients With Adult Stem Cell Therapy
Date:8/26/2013

Freeport, The Bahamas (PRWEB) August 26, 2013

Okyanos Heart Institute, whose mission is to bring a new standard of care and better quality of life to patients with coronary artery disease using cardiac stem cell therapy, announces that it has selected International Med-X and Philips Healthcare as its partner to establish the country’s first cath lab for stem cell therapy.

Philips is a global leader in cardiac imaging and has the largest share of the market of cardiac cath labs worldwide. International Med-X is the distributor for Philips Healthcare equipment in most of the English and Dutch-speaking Caribbean including The Bahamas offering sales and service for all Philips Healthcare products. Chief Medical Officer Howard T. Walpole, Jr., M.D., M.B.A., F.A.C.C., F.S.C.A.I. made the decision to go with Philips equipment specifically for the treatment of adult stem cell therapy.

“The most important functions of this equipment are to provide high quality images and to obtain the right projections of the image." said Walpole. “When you visualize a heart, you need to be able to get a complex angle to be able to see the back side of the heart. This enables the cardiologist to deliver the stem cells where they are most needed. The size of the image detector is smaller and the more flexible positioner makes it easier to pivot around the patient’s body to obtain those difficult views.”

The cath lab was shipped from Holland and is currently in Miami awaiting delivery to The Bahamas. Okyanos Heart Institute plans to begin treating patients in early 2014.

ABOUT OKYANOS HEART INSTITUTE: (Oh – key – AH – nos)
Based in Freeport, The Bahamas, Okyanos Heart Institute’s mission is to bring a new standard of care and a better quality of life to patients with coronary artery disease using cardiac stem cell therapy. Okyanos adheres to U.S. surgical center standards and is led by Chief Medical Officer Howard T. Walpole Jr., M.D., M.B.A., F.A.C.C., F.A.C.A.I. Okyanos Treatment utilizes a unique blend of stem and regenerative cells derived from one’s own adipose (fat) tissue. The cells, when placed into the heart via a minimally-invasive catheterization, stimulates the growth of new blood vessels, a process known as angiogenesis. The treatment facilitates blood flow in the heart and supports intake and use of oxygen (as demonstrated in rigorous clinical trials such as the PRECISE trial). The literary name Okyanos (“Oceanos”) symbolizes flow. For more information, go to http://www.okyanos.com/.

Royal Philips is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 116,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at http://www.philips.com/newscenter .

NEW MEDIA CONTENT:
Okyanos LinkedIn page:
http://www.linkedin.com/company/okyanos-heart-institute

Okyanos Facebook page:
https://www.facebook.com/OKYANOS

Okyanos Twitter page:
https://twitter.com/#!/OkyanosHeart

END

Read the full story at http://www.prweb.com/releases/2013/8/prweb11057428.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Okyanos Heart Institute Sponsors Stem Cell Resource Center on The American Journal of Cardiology Website
2. Okyanos Heart Institute’s Chief Medical Officer Speaks at ACC’s Scientific Session
3. Okyanos Heart Institute’s Chief Medical Officer To Speak At American College Of Cardiology Seminar In Florida
4. What is your heart attack risk?
5. Kenneth Bernstein, M.D., receives Distinguished Scientist designation from American Heart Association
6. AED.com Releases Philips HeartStart OnSite AED Demo Video
7. Drug dosing for older heart patients should differ
8. New Fresenius NaturaLyte, GranuFlo Dialysis Heart Attack Lawsuit Allegations Update: Resource4thePeople Reports Important Hearing Is Scheduled in Fresenius Multidistrict Litigation
9. Lower Cholesterol Naturally Say Doctors in News from HeartHealthySolution.com
10. Heartland Institute Experts Comment on Delay of Obamacare’s Out-of-Pocket Cost Limits
11. 10 Steps to Lower Stroke Risk, from the August 2013 Harvard Heart Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Frederick area economy by obtaining investment capital for emerging technology companies. ... years that have already resulted in more than a million dollars of capital ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Calif. , June 24, 2016  Global ... a biopharmaceutical company developing novel therapeutics for the ... needs, today announced the closing of its previously ... common stock, at the public offering price of ... the offering were offered by GBT. GBT estimates ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: ... and sells medical devices and wearable sleep respiratory products ... cooperation agreement with Hongyuan Supply Chain Management Co., Ltd. ... 20, 2016, to develop Dehaier,s new Internet medical technology ... will leverage Hongyuan Supply Chain,s sales platform to reach ...
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
Breaking Medicine Technology: